Huawei Xia
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Nanoplatforms for cancer theranostics 6
- Photoacoustic and Ultrasonic Imaging 3
- Co-authors
- Haibin Shi (7 shared papers)Ling Yin (4 shared papers)Mingyuan Gao (3 shared papers)Lei He (3 shared papers)Fuping You (4 shared papers)Hao Ran Sun (1 shared paper)Jianguo Lin (1 shared paper)Hao Zhang (1 shared paper)
In The Last Decade
Huawei Xia
16 papers receiving 620 citations
Peers
Comparison fields: 5 of 84
- Biomaterials 70
- Biomedical Engineering 218
- Immunology 99
- Molecular Biology 278
- Infectious Diseases 65
Countries citing papers authored by Huawei Xia
This map shows the geographic impact of Huawei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Xia more than expected).
Fields of papers citing papers by Huawei Xia
This network shows the impact of papers produced by Huawei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Xia. The network helps show where Huawei Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Huawei Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 185 | |
| 2 | 2019 | 151 | |
| 3 | 2021 | 57 | |
| 4 | 2023 | 51 | |
| 5 | 2021 | 33 | |
| 6 | 2018 | 30 | |
| 7 | 2018 | 23 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2017 | 14 | |
| 14 | 2019 | 8 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 3 |
About Huawei Xia
Huawei Xia is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Immunology and Cancer Research, having authored 16 papers that have together received 638 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (3 papers), Photoacoustic and Ultrasonic Imaging (3 papers), COVID-19 Clinical Research Studies (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Gold and Silver Nanoparticles Synthesis and Applications (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Biomaterials (70 citations), Biomedical Engineering (218 citations), Immunology (99 citations), Molecular Biology (278 citations) and Infectious Diseases (65 citations). Huawei Xia has collaborated with scholars based in China, France and Italy. Frequent co-authors include Haibin Shi, Ling Yin, Mingyuan Gao, Lei He, Fuping You, Hao Ran Sun, Jianguo Lin, Hao Zhang, Shun‐Jun Ji and Yuqi Zhang. Their work appears in journals such as Journal of Clinical Immunology, Analytical Chemistry, European Journal of Immunology, Viruses and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.